News

Essential Insights on Boston Scientific's Market Movements

Essential Insights on Boston Scientific's Market Movements

Boston Scientific's Intriguing Options Activity

Investors are making waves with a bearish stance on Boston Scientific (BSX).

This activity has raised eyebrows, especially among retail traders who keep a close watch on trading trends.

Today, remarkable trades surfaced, caught by options histories that reveal significant moves by investors in the market.

We may not know if these transactions originate from institutional investors or affluent individuals, but the unusual volume of activity often signifies that something substantial may be on the horizon for BSX.

How do we gather information about these investor activities?

Our analysis revealed that 26 uncommon options trades have been tracked for Boston Scientific recently.

This level of activity is certainly noteworthy and shows a distinct pattern.

Currently, big-money traders display a mixed sentiment, with 34% bullish and 53% bearish.

Among the options surfaced, we identified 13 puts, amounting to $508,332, while the calls totaled $1,246,734.

Projected Price Ranges

Taking the trading actions into account, it seems that significant investors are eyeing a price range between $84.0 and $92.5 for Boston Scientific over the past three months.

Understanding Volume and Open Interest

Examining volume and open interest provides valuable insights for trading options. This analytical approach helps track the level of liquidity and interest tied to Boston Scientific's options at various strike prices. The data below reveals recent trends in volume and open interest surrounding calls and puts for BSX within the strike price spectrum of $84.0 to $92.5 in the last month.

Highlights of Boston Scientific's Options Trends

...

Exceptional Options Trades Uncovered:

...

In the world of options trading, various strategies are used to predict future movements. Here, we will take a closer look at some of the most significant calls and puts identified above.

Company Overview: Boston Scientific

Boston Scientific is a leader in developing less invasive medical devices, which are inserted into the human body through minimal openings. The company produces devices used in numerous areas, including angioplasty, cardiac care, and treatment for chronic pain. With approximately half of its sales generated from international markets, the company has a solid global presence.

Current Market Insights

  • Today, BSX reported a trading volume of 5,183,134, with its share price slightly down by 0.07% to reach $88.01.
  • Recent RSI metrics suggest the stock may be overbought at present.
  • Investors should prepare as the next earnings report is due shortly.

Expert Opinions on Boston Scientific

In the past month, five seasoned analysts have shared their insights on BSX, setting an average target price of $93.8, reflecting diverse expectations.

One expert from TD Cowen maintains a Buy rating with a target of $100. Similarly, an analyst from Evercore ISI Group holds an Outperform rating with a target of $90. However, a revised action from Needham has adjusted the stock to Hold, targeting $86. Conversely, analysts from Stifel and BTIG have retained Buy ratings, both targeting $100 and $93, respectively.

Engaging in options trading involves inherent risks but also bears significant rewards. Savvy traders manage these by continuously learning, adapting their tactics, and observing market dynamics closely. To stay updated on Boston Scientific's options activity, consider leveraging real-time alerts from notable platforms.

Frequently Asked Questions

What are the recent trading trends for Boston Scientific?

Recent trades show a split sentiment with 34% bullish and 53% bearish among investors in BSX options.

What price range are investors targeting for BSX?

Investors seem to target prices between $84.0 and $92.5 for Boston Scientific based on recent trading activities.

What is the current market situation for Boston Scientific?

Currently, BSX is trading at $88.01, down by 0.07%, with an impressive trading volume of over 5 million shares.

What do analysts predict for Boston Scientific?

Analysts have provided an average price target of $93.8, with varying opinions ranging from Buy to Hold ratings.

Why is options trading significant for investors?

Options trading allows investors to leverage their positions, although it comes with greater risks compared to conventional trading.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

SlidesAI Launches Standalone Platform for Presentations

Updated Category News Views 95

From Add-on to Standalone: SlidesAI's Big Leap You know what they say: time waits for no one, and that seems true in tech too. Those suit-and-tie presentation days? SlidesAI just took a swing at redefining them. Once a trusty sidekick locked into Google Slides, it's now captaining its own ship. Welcome to the SlidesAI standalone presentation platform—where AI meets your...

Continue Reading
Investors Slam Coastal Financial: Class Action Looms Large

Updated Category News Views 51

The air's thick with tension as Coastal Financial Corporation (NASDAQ:CCB) finds itself embroiled in a securities class action lawsuit. Investors who grabbed shares between October 28, 2024, and July 29, 2026, are in the spotlight and urging those with losses to make a move by the December 1, 2026, lead plaintiff deadline. Sounds like a real mess, doesn't it? Well, it's a...

Continue Reading
Synova Global Taps Eventus for Top Trade Surveillance

Updated Category News Views 228

Synova and Eventus: A Powerful Partnership If you've ever traded a share or two, you know the name of the game is risk management. Step into Synova Global's latest move, and you'll see a gamble worth watching closely. This time around, Synova has tapped Eventus to bring their Validus trade surveillance platform into the fold. Now, Eventus and its star player, Validus,...

Continue Reading
RideNow Gears Up for Earnings Amidst Industry Shifts

Updated Category News Views 150

Highway to Earnings: RideNow's Third Quarter Call Alright, folks, this is the moment the powersports crowd has been itching for. RideNow Group, Inc. (NASDAQ: RDNW) is set to roll out their third-quarter financial results on November 10, 2026. If you're in for a wild ride—pun fully intended—mark this on your calendars. With this company hogging the spotlight in the...

Continue Reading
Swif.ai Paves Linux Path for Enterprise Developers

Updated Category News Views 92

The Quiet Revolution: Linux Takes Center Stage Linux, once the underdog of operating systems, is gaining significant traction in the world of AI development. It's not just a nerd's sandbox anymore; it's rapidly becoming the go-to platform for cutting-edge AI innovation. Now, more enterprise IT departments are facing the choice of keeping up with Linux's popularity—or...

Continue Reading
PG&E, Edison Push Liability Cap Amid Firestorm

Updated Category News Views 128

The Thanksgiving Playbook Nobody Wanted Sacramento's corridors are buzzing with electric tension. And why? It's not some trivial turkey drama but a simmering scandal over two utility giants trying to sneak a liability cap into law faster than you can ask for a second slice of pumpkin pie. PG&E and Edison have a little secret—a covert strategy to limit shareholder...

Continue Reading
Staypineapple Backs Vets: A Heartwarming Initiative

Updated Category News Views 151

When Hotels Stand Up for Heroes Every now and then, you stumble upon a company doing something genuinely good, and Staypineapple's effort this November is one of those rare gems. In honor of Veterans Day, they're opening their checkbook to sling some real support to our nation’s vets and retired first responders. Their chosen cause? The American Humane Society's...

Continue Reading
Viatris Declares Quarterly Dividend Amid Acquisition Buzz

Updated Category News Views 33

A Dividend Declaration with a Side of Mergers Viatris, the healthcare giant operating on a global scale, has been making some noise recently. On the surface, it's another quarterly dividend—$0.12 per share, set to hit the pockets of shareholders on December 16. But there's a lot more cooking under the hood of this announcement that ticks just about every box for a...

Continue Reading
LITE, RRC, SGRY: Are Shareholders Getting Shortchanged?

Updated Category News Views 51

What's Really Going On Here? Here's the skinny: Halper Sadeh LLC, that hard-hitting investor rights law firm, is poking their noses into some potential red flags over at a few companies you might have heard of—Lumentum Holdings (NASDAQ:LITE), Range Resources (NYSE:RRC), and Surgery Partners (NASDAQ:SGRY). They're sniffing around transactions that might leave the regular...

Continue Reading
WuXi Biologics Racks Up Top Honors for ESG Excellence

Updated Category News Views 60

WuXi Strikes Gold with ESG Distinction Take a look under the hood, and you’ll find that WuXi Biologics (2269.HK) isn’t just playing the long game—they’re redefining it. They’ve clinched not one, but two prestigious honors from the Hong Kong ESG Reporting Awards (HERA). And with sustainability in the hot seat worldwide, these wins are no small potatoes. They...

Continue Reading

Top 5 Most Recently Viewed Articles

Encore Wound Care Celebrates a Stellar Growth Milestone

Updated Category News Views 140

Encore Wound Care Recognized Among America's Fastest-Growing Companies Encore Achieves New Heights with Impressive Revenue Growth Encore Wound Care has made a remarkable entrance onto the Inc. 5000 list, showcasing its impressive three-year revenue growth of 6,745%. This accolade places Encore at No. 32 overall, while also ranking it No. 2 within its home state and No. 9...

Continue Reading
Magyar Bancorp Achieves KBW Bank Honor Roll Recognition Again

Updated Category News Views 290

Magyar Bancorp's Prestigious Recognition in Banking In a noteworthy achievement, Magyar Bancorp, Inc. (NASDAQ: MGYR), the parent company of Magyar Bank, has secured a position on the prestigious KBW Bank Honor Roll for 2025. This accolade highlights the remarkable performance of this institution within a select group of 16 elite banks, showcasing those that exhibit the...

Continue Reading
Open Lending Corporation Faces Class Action Investors Alert

Updated Category News Views 243

Class Action Lawsuit Against Open Lending Corporation Open Lending Corporation is currently facing serious allegations that have sparked interest among investors. Robbins LLP has come forward to inform all stockholders that a class action lawsuit has been initiated on behalf of those who purchased or acquired stocks during a specific period. This lawsuit has drawn...

Continue Reading
First Global Schools Earn Cognia Certification

Updated Category News Views 10

Breaking New Ground in Global Education Who would've thought that two schools outside the U.S. would be the first to snag the Cognia American School Certification? Yep, John F. Kennedy, The American School of Querétaro in Mexico, and Union School in Haiti have paved the way. This certification ain't just a sticker; it's about meeting a laundry list of rigorous...

Continue Reading
AstraZeneca Investors Interest in Class Action Lawsuit Update

Updated Category News Views 236

AstraZeneca Class Action Lawsuit: What Investors Need to Know Recent developments at AstraZeneca PLC (NASDAQ: AZN) show a significant opportunity for investors who purchased the pharmaceutical company's securities within a specific time frame. The Rosen Law Firm has initiated a class action lawsuit aimed at addressing securities fraud claims that impact numerous...

Continue Reading